Search Results for 'hcv genotype'

hcv genotype published presentations and documents on DocSlides.

Abbott RealTime HCV Genotype II PMA                CONFIDENTIAL
Abbott RealTime HCV Genotype II PMA CONFIDENTIAL
by desha
mHCV Genotype II Key to symbols used Global Tra...
Sofosbuvir-Velpatasvir  in HCV Genotype 1, 2, 4, 5, or 6
Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6
by pasty-toler
ASTRAL-1. Phase 3. . Treatment. . Naïve & ...
% of Global HCV Seropositive Cases
% of Global HCV Seropositive Cases
by faith
Global epidemiology of hepatitis C virus infection...
≥ 18 years HCV genotype 1, 2, 4, 5, 6
≥ 18 years HCV genotype 1, 2, 4, 5, 6
by alexa-scheidler
HCV RNA ≥ 1000 IU/mL. Treatment-naïve or treat...
This product is intended to be used to guide the selection of treatmen
This product is intended to be used to guide the selection of treatmen
by rosemary
siemens.com/molecular Optimize Treatment Decisions...
Emergence of a HCV genotype genomic variant with
Emergence of a HCV genotype genomic variant with
by kittie-lecroy
Emergence of a HCV genotype genomic variant with e...
FISSION Design Objective
FISSION Design Objective
by travis
Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...
Boceprevir  with PEG + RBV in Genotype 1
Boceprevir with PEG + RBV in Genotype 1
by caroline
SPRINT. -1. Phase . 2. Treatment. . Naïve. Kwo. ...
Ghazala   Rubi B.Sc ,  M.Sc
Ghazala Rubi B.Sc , M.Sc
by badra
,. F.I.B.M.S;. MPhil. (. Mol.Bio. ). PhD (Human G...
OBV/PTV/r    DSV    RBV OBV/PTV/r
OBV/PTV/r DSV RBV OBV/PTV/r
by ellena-manuel
DSV . placebo. Randomisation*. Partial blind. 1...
Sofosbuvir-Velpatasvir  in Genotype 2
Sofosbuvir-Velpatasvir in Genotype 2
by stefany-barnette
ASTRAL-2*. Phase 3. . Treatment. . Naïve &...
Telaprevir
Telaprevir
by karlyn-bohler
BID versus q8 in Treatment Naïve GT-1. OPTIMIZE ...
LDV/SOF 90/400 mg
LDV/SOF 90/400 mg
by aaron
qd. Non-randomised. Open-label. N =. 21. W12. SV...
OBV/PTV/r
OBV/PTV/r
by conchita-marotz
OBV/PTV/r + RBV. Randomisation*. 1 : 1. Open labe...
SAPPHIRE-I
SAPPHIRE-I
by ellena-manuel
Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...
Are Pan-Genotypic Therapies Ready for Prime Time?
Are Pan-Genotypic Therapies Ready for Prime Time?
by lois-ondreau
3. Rd. International . HIV/Hepatitis . Coinfecti...
Hepatitis C Drug 		 	   Pipeline
Hepatitis C Drug Pipeline
by cheryl-pisano
HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...
Future HCV Treatment Paradigms
Future HCV Treatment Paradigms
by kittie-lecroy
Mark Sulkowski, MD . Professor of Medicine. Medic...
Sofosbuvir + Ribavirin in HCV Genotype 1
Sofosbuvir + Ribavirin in HCV Genotype 1
by pamella-moone
NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...
Elbasvir-Grazoprevir   in Treatment-Naïve HCV Genotype 1, 4 or 6
Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6
by celsa-spraggs
C-EDGE Treatment Naïve (TN). Phase 3. . Treatme...
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
by danika-pritchard
NIAID Retreatment. Phase . 2a . Treatment. . Exp...
C-SCAPE
C-SCAPE
by pasty-toler
Design. C-SCAPE . Study. : . grazoprevir. ± . e...
OBV/PTV/r   DSV Open label
OBV/PTV/r DSV Open label
by kittie-lecroy
≥ 18 years. Chronic HCV infection. Genotype 1. ...
SMV 150 mg QD   SOF 400 mg QD
SMV 150 mg QD SOF 400 mg QD
by alida-meadow
Randomisation. 1 : 1. 18-70 years. HCV genotype 1...
Placebo + PR
Placebo + PR
by aaron
W24. DCV + PR. Placebo + PR. Yes. Dore GJ. Gastro...
NIAID ERADICATE
NIAID ERADICATE
by tatiana-dople
Open-label. W12. ≥ 18 years. Chronic HCV infect...
C-SCAPE
C-SCAPE
by tawny-fly
Design. C-SCAPE . Study. : . grazoprevir. ± . e...
SOF/VEL
SOF/VEL
by lois-ondreau
400/100 mg . qd. N = 500. N = 100. W12. Placebo. ...
SMV 150 mg
SMV 150 mg
by faustina-dinatale
qd. + SOF 400 mg . qd. N = 40. W12. 18-70 years....
www.hcvadvocate.org BLOG:  hcvadvocate.blogspot.com
www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com
by luanne-stotts
. HCV Training Workshop. Version 19.0. HCSP/HCV ...
Hepatitis C Overview 1 Updated 9/20/2017
Hepatitis C Overview 1 Updated 9/20/2017
by liane-varnes
2. Introduction . Self-Advocacy through Education...
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
by kittie-lecroy
Interim Analysis of a French Multicenter Compassi...
Hepatitis C Imtiaz Alam, M.D.
Hepatitis C Imtiaz Alam, M.D.
by olivia-moreira
Medical Director, Austin Hepatitis Center. 1. Hep...
Telaprevir  BID versus q8 in Treatment Naïve GT-1
Telaprevir BID versus q8 in Treatment Naïve GT-1
by volatilenestle
OPTIMIZE (. Study . C211). Phase . 3. Treatment. ...
SMV + DCV + SOF Open label
SMV + DCV + SOF Open label
by summer
≥ 18 years. Chronic HCV infection. Genotype 1 or...
Internal ControlExpiration DateAmplification Reagent PackCAUTION Hand
Internal ControlExpiration DateAmplification Reagent PackCAUTION Hand
by carny
is proportional to the log of the HCV RNA concentr...
CORPORATE HEADQUARTERS
CORPORATE HEADQUARTERS
by yvonne
3043-02 904 Caribbean Drive Sunnyvale, CA 94089 US...
Hepatitis C  Dr.  Alipour
Hepatitis C Dr. Alipour
by beatrice
Chronic hepatitis C virus (HCV) infection is one o...
TURQUOISE-II
TURQUOISE-II
by giovanna-bartolotta
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
Breakout session Ryan White
Breakout session Ryan White
by lydia
Marion Peters. August 2020. ARS Question 1:. Which...